Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Clinical trial NCT00678587 · TERMINATED

Trial details

NCT number: NCT00678587
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-alcoholic Steatohepatitis Chronic Liver Disease HCV NASH - Nonalcoholic Steatohepatitis HIV Infection Thrombocytopenia Hepatitis C Virus HBV Human Immunodeficiency Virus Liver Diseases Hepatitis B Virus

Start date: 2008-06-01
Primary completion: 2009-10-01
Enrollment: 292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.